Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Jeremy Neil Ruskin, M.D.

Co-Author

This page shows the publications co-authored by Jeremy Ruskin and Patrick Ellinor.
Connection Strength

1.290
  1. New classification scheme for atrial fibrillation symptom severity and burden. Am J Cardiol. 2014 Jul 15; 114(2):260-5.
    View in: PubMed
    Score: 0.148
  2. Challenges in the classification of atrial fibrillation. Nat Rev Cardiol. 2010 Aug; 7(8):451-60.
    View in: PubMed
    Score: 0.113
  3. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. Acad Emerg Med. 2010 Mar; 17(3):297-306.
    View in: PubMed
    Score: 0.111
  4. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J. 2009 Apr; 30(7):813-9.
    View in: PubMed
    Score: 0.102
  5. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm. 2008 Jan; 5(1):99-105.
    View in: PubMed
    Score: 0.093
  6. Fungal infection of implantable cardioverter-defibrillators: case series of five patients managed over 22 years. Heart Rhythm. 2006 Aug; 3(8):919-23.
    View in: PubMed
    Score: 0.085
  7. Impact of the multicenter automatic defibrillator implantation trial on clinical practice. Ann Noninvasive Electrocardiol. 2006 Jan; 11(1):20-7.
    View in: PubMed
    Score: 0.083
  8. Familial aggregation in lone atrial fibrillation. Hum Genet. 2005 Nov; 118(2):179-84.
    View in: PubMed
    Score: 0.082
  9. Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol. 2005 Jul; 28(7):630-8.
    View in: PubMed
    Score: 0.080
  10. Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart. 2004 Dec; 90(12):1487-8.
    View in: PubMed
    Score: 0.077
  11. Variability in implantable cardioverter defibrillator pulse generator longevity between manufacturers. Pacing Clin Electrophysiol. 2003 Jan; 26(1 Pt 1):71-5.
    View in: PubMed
    Score: 0.067
  12. Effect of a Multidisciplinary Approach for the Management of Patients With Atrial Fibrillation in the Emergency Department on Hospital Admission Rate and Length of Stay. Am J Cardiol. 2016 Jul 01; 118(1):64-71.
    View in: PubMed
    Score: 0.042
  13. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Europace. 2012 Sep; 14(9):1287-93.
    View in: PubMed
    Score: 0.032
  14. Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm. 2012 May; 9(5):717-20.
    View in: PubMed
    Score: 0.031
  15. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm. 2010 May; 7(5):639-44.
    View in: PubMed
    Score: 0.028
  16. Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature. Heart Rhythm. 2008 Dec; 5(12):1667-72.
    View in: PubMed
    Score: 0.025
  17. Catheter ablation of peri-AV nodal atrial tachycardia from the noncoronary cusp of the aortic valve. J Cardiovasc Electrophysiol. 2008 Mar; 19(3):231-7.
    View in: PubMed
    Score: 0.024
  18. Ablation of atrial flutter in a patient with situs inversus totalis using integration of real-time three-dimensional electroanatomical mapping. J Cardiovasc Electrophysiol. 2008 Feb; 19(2):221-2.
    View in: PubMed
    Score: 0.023
  19. Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2006 Oct; 17(1):21-7.
    View in: PubMed
    Score: 0.022
  20. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm. 2007 Apr; 4(4):439-42.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.